PF-Atlas › Clinical Trials › NCT04624490

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Hyperpolarized Xe129 · Phase 1

Registry ID
NCT04624490
Phase
Phase 1
Status
Recruiting
Drug / intervention
Hyperpolarized Xe129
Sponsor
Mario Castro, MD, MPH
Start
2020-11-02
Enrollment
260
Locations
1

About this trial

The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

View NCT04624490 on ClinicalTrials.gov →

Explore related

All Hyperpolarized Xe129 trialsAll IPF trials

Related trials

Hyperpolarized Xe129 — NCT06853145Hyperpolarized Xe129 — NCT04677426
Medical disclaimer. This page summarizes public trial data for NCT04624490 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.